Edwards Lifesciences Liability For Uncertain Tax Positions Noncurrent increased by 10.5% to $555.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 38.0%, from $402.60M to $555.40M. Over 5 years (FY 2020 to FY 2025), Liability For Uncertain Tax Positions Noncurrent shows an upward trend with a 18.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase suggests higher tax audit risk or aggressive tax planning, while a decrease indicates the resolution of past tax uncertainties.
This represents the estimated liability for tax positions taken by the company that may be challenged by tax authorities...
Standard for multinational corporations operating in multiple jurisdictions with complex tax environments.
non_current_liabilities_liability_for_uncertain_tax_posi_541f68| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $234.20M | $245.40M | $259.00M | $270.70M | $282.40M | $295.60M | $267.50M | $284.00M | $303.70M | $312.10M | $339.30M | $336.60M | $343.20M | $345.60M | $384.60M | $402.60M | $421.60M | $442.90M | $502.70M | $555.40M |
| QoQ Change | — | +4.8% | +5.5% | +4.5% | +4.3% | +4.7% | -9.5% | +6.2% | +6.9% | +2.8% | +8.7% | -0.8% | +2.0% | +0.7% | +11.3% | +4.7% | +4.7% | +5.1% | +13.5% | +10.5% |
| YoY Change | — | — | — | — | +20.6% | +20.5% | +3.3% | +4.9% | +7.5% | +5.6% | +26.8% | +18.5% | +13.0% | +10.7% | +13.4% | +19.6% | +22.8% | +28.2% | +30.7% | +38.0% |